Plain-English translation of NCT06648772 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial tested (Zoryve®), a new topical treatment applied directly to the skin, to see how well it works for plaque psoriasis compared to a dummy cream with no active ingredient. The study enrolled participants in China aged 6 and older who had plaque psoriasis affecting a limited area of their body. Researchers examined both how effective the medication was and how safe it was to use.
Plaque psoriasis can be difficult to manage, and patients need more treatment options that are safe and effective, especially for younger people. This trial investigated whether this new topical treatment could offer patients a helpful way to control their symptoms.
Participants were randomly assigned to apply either the new cream or a placebo cream once daily to their affected skin areas. The trial was double-blind, meaning neither the participants nor the researchers knew which treatment each person was receiving. Participants attended multiple visits where researchers checked how their psoriasis was responding and monitored them for any side effects.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
China